Can chemotherapy cause vision changes?

Translate to Spanish or other 102 languages!

 Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention. Image for illustration purposes
Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention. Image for illustration purposes
- Advertisement -

Chemotherapy can affect a person’s vision. Although most changes usually stop after the treatment, some may last longer. Sudden vision changes need immediate medical attention.

While most vision side effects are temporary, some can also be long term. Healthcare professionals can help people manage these changes to their vision.

This article discusses how chemotherapy affects vision, how long the side effects may last, and which chemotherapy drugs can affect vision. It also discusses how people can manage chemotherapy vision changes.

- Advertisement -

Follow the link below to read the full story at Medical News Today:

https://www.medicalnewstoday.com/articles/can-chemotherapy-affect-your-vision?slot_pos=article_3&utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2024-10-14&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

New Strategies to Soothe Dry Eyes

Anyone who has ever endured burning, itchy eyes or extra tearing knows that these symptoms are tough to ignore.

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
- Advertisement -